CD39 (ENTPD1) Mouse Monoclonal Antibody [Clone ID: OTI2B10]

  • Product Brand Image
SKU
TA804559
ENTPD1 mouse monoclonal antibody, clone OTI2B10 (formerly 2B10)
  $447.00
In Stock*
Bulk/Customize
Specifications
Specifications
Product Data
Clone Name OTI2B10
Application IHC, WB
Recommended Dilution WB 1:2000, IHC 1:150
Reactivity Human
Antibody Host Mouse
Isotype IgG1
Clonality Monoclonal
Immunogen Human recombinant protein fragment corresponding to amino acids 38-307 of human ENTPD1 (NP_001767) produced in E.coli.
Buffer PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide
Concentration 1 mg/ml
Purification Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G)
Conjugation Unconjugated
Storage Store at -20°C as received.
Stability Stable for 12 months from date of receipt.
Shipping Blue Ice
Gene Name ectonucleoside triphosphate diphosphohydrolase 1
Database Link
Synonyms ATPDase; CD39; NTPDase-1; SPG64
Reference Data
Protein Categories ADC Targets, CD Markers, Membrane Proteins, Nervous system Diseases
Protein Families Transmembrane
Protein Pathways Purine metabolism, Pyrimidine metabolism
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources
Other "OTI2B10" antibodies (4)
SKU Description Size Price
CF804559 Carrier-free (BSA/glycerol-free) ENTPD1 mouse monoclonal antibody, clone OTI2B10 (formerly 2B10) 100 ug
$620.00
TA804559AM ENTPD1 mouse monoclonal antibody, clone OTI2B10 (formerly 2B10), Biotinylated 100 ul
$509.00
TA804559BM ENTPD1 mouse monoclonal antibody, clone OTI2B10 (formerly 2B10), HRP conjugated 100 ul
$509.00
TA804559S ENTPD1 mouse monoclonal antibody, clone OTI2B10 (formerly 2B10) 30 ul
$200.00

file-alt Citations

Sequential involvement of hypoxia and anti-PD-1 treatment in shaping tumor-regional CD39+CD8+ T cells highlights immunotherapy-resistant features in NSCLC
Wu, Zhai, Lv et al
J Immunother Cancer (2026) 14 (6) DOI: 10.1136/jitc-2026-014940
AI Summary: In this study, the OriGene rat anti-human CD39 monoclonal antibody (Cat# TA804559) was used for immunofluorescent staining to identify and analyze CD39+CD8+ T cells within the tumor microenvironment of NSCLC, contributing to the investigation of their spatial distribution and role in immunotherapy resistance.
Snippet: quential immunofluorescent staining for CD39, CD8, and hypoxia-inducible factor 1-alpha (HIF-1α) was then performed in successive rounds. Primary antibodies used were rat anti-human CD39 mAb (1:150, OriGene, Cat# TA804559;RRID: AB_2627349), rabbit anti-human CD8 mAb (1:300, ZSGB-Bio, Cat# ZA-0508;RRID: AB_2890107), and rat anti-human HIF-1α mAb (1:400, Proteintech, Cat# 20960–1 AP;RRID: A
FigureFigureFigure
Epithelial microRNA-206 targets CD39/extracellular ATP to upregulate airway IL-25 and TSLP in type 2-high asthma
Zhang, Feng, Liang et al
JCI Insight (2021)
Cited by 36
AI Summary: OriGene’s monoclonal mouse-anti-human CD39 antibody (clone OTI2B10) was used in this study to detect CD39 protein expression in cells by Western blotting, enabling the authors to investigate the regulatory role of miR-206 on CD39 in type 2-high asthma.
Snippet: CD39 protein expression in cells was detected with monoclonal mouse-anti-human CD39antibody (clone OTI2B10, OriGene Technologies) using Western blotting as previously described
WB
Showing 1-2 of 2 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products